• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Ventas

Ventas

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Ventas Announces Second Quarter 2016 Earnings Release Date and Conference Call

    Ventas Announces Second Quarter 2016 Earnings Release Date and Conference Call

  2. Ventas Signs $1.5 Billion Life Sciences-Focused Deal

    Ventas Signs $1.5 Billion Life Sciences-Focused Deal

  3. Ventas Signs $1.5 Billion Life Sciences-Focused Deal

    Ventas Signs $1.5 Billion Life Sciences-Focused Deal

  4. Ventas Adds Value

    Ventas ’ spin-off of skilled nursing facilities and Ardent acquisition add value for shareholders.

  5. Healthy Outlook for Undervalued Landlord

    Although we think Ventas overpaid for its most recent acquisitions, this doesn't affect our valuation.

  6. A Matter of Time for Health-Care REITs

    We prefer the yield, stability, and growth prospects of the triple-net structure over RIDEA.

  7. Reasonable Leverage, Growth Prospects, Moats, and Valuation Guide Our REIT Picks

    Our favorites can do well even with potentially higher interest rates.

  8. Real Estate: Rising Interest Rates Wreak Havoc on REITs

    We prefer REITs with reasonable leverage, moaty assets, demonstrated historical success across economic cycles, identifiable growth drivers, and reasonable margins of safety.

  9. 4 Dividend Payers for a Higher-Rate World

    Trying to time interest-rate increases is less important than choosing companies with a good margin of safety that you can hold through thick and thin, says Morningstar's Josh Peters.

  10. 4 REITs That Can Weather Through Rising Rates

    Rising interest rates can be a valuation headwind for the REIT sector, but some REITs are better positioned than others, says Morningstar's Todd Lukasik.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.